Cargando…
In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses
BACKGROUND: GM1 and GM2 gangliosidoses are progressive neurodegenerative lysosomal storage diseases resulting from the excessive accumulation of GM1 and GM2 gangliosides in the lysosomes, respectively. The diagnosis of gangliosidosis is carried out based on comprehensive findings using various types...
Autores principales: | Kohyama, Moeko, Yabuki, Akira, Ochiai, Kenji, Nakamoto, Yuya, Uchida, Kazuyuki, Hasegawa, Daisuke, Takahashi, Kimimasa, Kawaguchi, Hiroaki, Tsuboi, Masaya, Yamato, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815186/ https://www.ncbi.nlm.nih.gov/pubmed/27036194 http://dx.doi.org/10.1186/s12917-016-0691-y |
Ejemplares similares
-
Thymic Alterations in GM2 Gangliosidoses Model Mice
por: Kanzaki, Seiichi, et al.
Publicado: (2010) -
The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment
por: Toro, Camilo, et al.
Publicado: (2021) -
The diagnostic journey for patients with late-onset GM2 Gangliosidoses
por: Lopshire, Mariah C., et al.
Publicado: (2023) -
GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies
por: Leal, Andrés Felipe, et al.
Publicado: (2020) -
Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
por: Zhang, Wenchao, et al.
Publicado: (2019)